Association between kynurenine pathway metabolites and psychotropic medications in bipolar disorder: An exploratory study in the FACE-BD cohort.

Etain B, Hennion V, Autier V, Raynal S, Godin O, Aouizerate B, Belzeaux R, Courtet P, Dubertret C, Lefrere A, Olié E, Polosan M, Roux P, Schwan R, Samalin L, Fondamental Advanced Centers Of Expertise In Bipolar Disorders (FACE-BD) Collaborators, Leboyer M, Marie-Claire C, Gil S

Open source

DOI: 10.1016/j.pnpbp.2026.111891
Published: 2026 Aug 30
Container: Progress in neuro-psychopharmacology & biological psychiatry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.pnpbp.2026.111891,
  title = {Association between kynurenine pathway metabolites and psychotropic medications in bipolar disorder: An exploratory study in the FACE-BD cohort.},
  author = {Etain B and Hennion V and Autier V and Raynal S and Godin O and Aouizerate B and Belzeaux R and Courtet P and Dubertret C and Lefrere A and Olié E and Polosan M and Roux P and Schwan R and Samalin L and Fondamental Advanced Centers Of Expertise In Bipolar Disorders (FACE-BD) Collaborators and Leboyer M and Marie-Claire C and Gil S},
  year = {2026},
  journal = {Progress in neuro-psychopharmacology \& biological psychiatry},
  doi = {10.1016/j.pnpbp.2026.111891},
  url = {https://doi.org/10.1016/j.pnpbp.2026.111891}
}

RIS

TY  - JOUR
TI  - Association between kynurenine pathway metabolites and psychotropic medications in bipolar disorder: An exploratory study in the FACE-BD cohort.
AU  - Etain B
AU  - Hennion V
AU  - Autier V
AU  - Raynal S
AU  - Godin O
AU  - Aouizerate B
AU  - Belzeaux R
AU  - Courtet P
AU  - Dubertret C
AU  - Lefrere A
AU  - Olié E
AU  - Polosan M
AU  - Roux P
AU  - Schwan R
AU  - Samalin L
AU  - Fondamental Advanced Centers Of Expertise In Bipolar Disorders (FACE-BD) Collaborators
AU  - Leboyer M
AU  - Marie-Claire C
AU  - Gil S
PY  - 2026
JO  - Progress in neuro-psychopharmacology & biological psychiatry
DO  - 10.1016/j.pnpbp.2026.111891
UR  - https://doi.org/10.1016/j.pnpbp.2026.111891
ER  -

APA

B, E., V, H., V, A., S, R., O, G., B, A., R, B., P, C., C, D., A, L., E, O., M, P., P, R., R, S., L, S., Collaborators, F. A. C. O. E. I. B. D. (., M, L., C, M., & S, G. (2026). Association between kynurenine pathway metabolites and psychotropic medications in bipolar disorder: An exploratory study in the FACE-BD cohort.. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2026.111891

Source records

pubmed · retrieved 2026-09-25T17:31:35.519Z